CCRB Logo

Modification History

CUHK_CCT00121

Effects of Different Dosages of intravitreal Bevacizumab (Avastin) for Neovascular Age-related Macular Degeneration: A Randomized Controlled Trial

2007-07-18

Update Date Recruitment Status Modified By  
2011-02-08 Complete Administrator Detail
2009-11-24 Complete Registry User Detail
2009-11-19 Recruiting Administrator Detail
2007-07-18 Recruiting Registry User Detail
Back